Trulicity 0.75 mg solution for injection in pre-filled pen
Phase 3 small_molecule active
Quick answer
Trulicity 0.75 mg solution for injection in pre-filled pen for Preventive treatment of post-kidney transplant diabetes is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Preventive treatment of post-kidney transplant diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active